Jeffrey S. Thompson

5.6k citations

63 papers · 3.7k indexed · 1 hit paper · h-index 25

Immunology top 2%
Molecular Biology top 5%
Genetics top 5%
Cancer Research top 5%
Oncology top 10%

Co-authors: Fang Qian Teresa G. Cachero Christine Ambrose Jeffrey L. Browning Pascal Schneider Jürg Tschopp Michael Grunstein Christopher D. Benjamin
Topics: DNA Repair Mechanisms (7 papers)Genomics and Chromatin Dynamics (7 papers)Mercury impact and mitigation studies (7 papers)
Cited by: Immunology Cancer Research Rheumatology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Switzerland Australia

In The Last Decade

Jeffrey S. Thompson

60 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF

2001 751 citations Jeffrey S. Thompson, Sarah A. Bixler et al. profile →

Peers

Countries citing papers authored by Jeffrey S. Thompson

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Thompson more than expected).

Fields of papers citing papers by Jeffrey S. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Thompson. The network helps show where Jeffrey S. Thompson may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Thompson. A scholar is included among the top collaborators of Jeffrey S. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Thompson. Jeffrey S. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An epigenetically inherited UV hyper-resistance phenotype in Saccharomyces cerevisiae 2022 ·Epigenetics & Chromatin ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jeffrey S. Thompson	8
2	Efficient and Precise Processing of the Optimized Primary Artificial MicroRNA in a Huntingtin-Lowering Adeno-Associated Viral Gene Therapy In Vitro and in Mice and Nonhuman Primates 2021 ·Human Gene Therapy ·Wei Wang,Pengcheng Zhou,Xin Wang,Fen Chen,(unknown),Jeffrey S. Thompson,Xiao‐Qin Ren,Adrian P. Kells,Lisa M. Stanek,(unknown),Jay Hou,Dinah W.Y. Sah	9
3	Compression of the S1 Nerve Root by an Extradural Vascular Malformation: A Case Report and Discussion of Atypical Causes of Lumbar Radiculopathy 2020 ·The International Journal of Spine Surgery ·Jeffrey S. Thompson,Robert Merrill,Sheeraz A. Qureshi,Dante M. Leven	3
4	Fascia Iliaca Block Decreases Hip Fracture Postoperative Opioid Consumption: A Prospective Randomized Controlled Trial 2019 ·Journal of Orthopaedic Trauma ·Jeffrey S. Thompson,(unknown),(unknown),(unknown),David K. Galos,(unknown),Charles Ruotolo	28
5	Lessons learned and best practices derived from environmental monitoring at a large-scale CO2 injection project 2018 ·International journal of greenhouse gas control ·(unknown),Nicholas A. Azzolina,(unknown),(unknown),(unknown),(unknown),(unknown),Jeffrey S. Thompson,(unknown),John Hamling,Charles D. Gorecki	2
6	Histone H3 K79 methylation states play distinct roles in UV-induced sister chromatid exchange and cell cycle checkpoint arrest in Saccharomyces cerevisiae 2014 ·Nucleic Acids Research ·(unknown),Anna L. Boudoures,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jeffrey S. Thompson	14
7	Contributions of Histone H3 Nucleosome Core Surface Mutations to Chromatin Structures, Silencing and DNA Repair 2011 ·PLoS ONE ·Michel Fink,Jeffrey S. Thompson,Fritz Thoma	4
8	Sorbent injection into a slipstream baghouse for mercury control: Project summary 2009 ·Fuel Processing Technology ·Jeffrey S. Thompson,John H. Pavlish,(unknown),(unknown),David R. Smith,(unknown),(unknown)	12
9	UV sensitive mutations in histone H3 in Saccharomyces cerevisiae that alter specific K79 methylation states genetically act through distinct DNA repair pathways 2008 ·Current Genetics ·Margery L. Evans,(unknown),(unknown),Andrew Keller,Natasha T. Strande,Jeffrey S. Thompson	14
10	Dose Proportionality of Fentanyl Buccal Tablet in Healthy Japanese Volunteers 2008 ·PubMed ·Mona Darwish,(unknown),John Jiang,Jeffrey S. Thompson,(unknown)	2
11	Methylation of histone H3 lysine-79 by Dot1p plays multiple roles in the response to UV damage in Saccharomyces cerevisiae 2007 ·DNA repair ·(unknown),Andrew Keller,(unknown),(unknown),Jeffrey S. Thompson	70
12	Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus Oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 μg: A single-dose, randomized, open-label, three-period study in healthy adult volunteers 2006 ·Clinical Therapeutics ·Mona Darwish,(unknown),Mary Kirby,Jeffrey S. Thompson	47
13	Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy Volunteers 2005 ·Clinical Pharmacokinetics ·Mona Darwish,(unknown),Mary Kirby,Jeffrey S. Thompson	44
14	B Cell-Activating Factor Belonging to the TNF Family (BAFF)-R Is the Principal BAFF Receptor Facilitating BAFF Costimulation of Circulating T and B Cells 2004 ·The Journal of Immunology ·Lai Guan Ng,Andrew P. R. Sutherland,Rebecca Newton,Fang Qian,Teresa G. Cachero,Martin Scott,Jeffrey S. Thompson,Julie Wheway,Tatyana Chtanova,Joanna R. Groom,Ian Sutton,(unknown),Stuart G. Tangye,Susan L. Kalled,Fabienne Mackay,Charles R. Mackay	401
15	Development of a Mercury Transformation Model in Coal Combustion Flue Gas 2004 ·Environmental Science & Technology ·Ye Zhuang,Jeffrey S. Thompson,Christopher J. Zygarlicke,John H. Pavlish	62
16	Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF 2003 ·Journal of Biological Chemistry ·Marc R. Pelletier,Jeffrey S. Thompson,Fang Qian,Sarah A. Bixler,(unknown),Teresa G. Cachero,Kevin Gilbride,Eric S. Day,Mohammad Zafari,(unknown),Leonid Gorelik,Adrian Whitty,Susan L. Kalled,Christine Ambrose,Yen‐Ming Hsu	79
17	T10B9 action: The effect of anti-t-cell antibody mitogenicity and graft rejection on the first dose cytokine response 1997 ·Transplantation Proceedings ·Stephen Brown,Bruno Lucas,Thomas Waid,(unknown),(unknown),Jeffrey S. Thompson	2
18	Specific repression of the yeast silent mating locus HMR by an adjacent telomere 1994 ·Molecular and Cellular Biology ·Jeffrey S. Thompson,Lianna M. Johnson,Michael Grunstein	18
19	Loss of Imprinting in Human Cancer 1994 ·Cold Spring Harbor Symposia on Quantitative Biology ·Andrew P. Feinberg,Linda M. Kalikin,Laura A. Johnson,Jeffrey S. Thompson	20
20	Histone H3 amino terminus is required for telomeric and silent mating locus repression in yeast 1994 ·Nature ·Jeffrey S. Thompson,Xuefeng B. Ling,Michael Grunstein	195

About Jeffrey S. Thompson

Jeffrey S. Thompson is a scholar working on Geochemistry and Petrology, Aging and Anesthesiology and Pain Medicine, having authored 63 papers that have together received 3.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), Genomics and Chromatin Dynamics (7 papers) and Mercury impact and mitigation studies (7 papers). The work is most often cited by research in Immunology (1.5k citations), Cancer Research (401 citations) and Rheumatology (330 citations). Jeffrey S. Thompson has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Fang Qian, Teresa G. Cachero, Christine Ambrose, Jeffrey L. Browning, Pascal Schneider, Jürg Tschopp, Michael Grunstein, Christopher D. Benjamin, Martin Scott and Mohammad Zafari. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact